Crossmark

Low influenza, pneumococcal and herpes zoster vaccination coverage in Australian patients commencing a biologic or targeted synthetic disease modifying anti-rheumatic drug for inflammatory arthritis: a nationwide cross-sectional data linkage study

Crossref DOI link: https://doi.org/10.1007/s00296-025-06019-7

Published Online: 2025-11-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wong, Peter K. https://orcid.org/0000-0002-2182-1815
O’Sullivan, Matthew https://orcid.org/0000-0001-8783-5323
Deng, Lucy https://orcid.org/0000-0003-0066-2218
Funding

Funding for this research was provided by:

UCB (UCB)

AbbVie (AbbVie)
License Information

Text and Data Mining valid from 2025-11-13

Version of Record valid from 2025-11-13
More Information

Article History

Received: 20 August 2025

Accepted: 17 October 2025

First Online: 13 November 2025

Declarations

:

: The authors declare no known competing financial interests or personal relationships that influenced the work reported in this paper.

: Not required.

Document is current

Any future updates will be listed below